Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer lhrh luteinizing prostate trelstar |
|
How Is Prostate Cancer Treated? - Caring4Cancer If there is any good news involving prostate cancer, it is that there are variety of LHRH (luteinizing hormone-releasing hormone) analogs - These drugs LH and RH agonist info, LH and RH agonist media, health & medical LH and RH agonists are useful in the treatment of prostate cancer. acetate Trelstar Depot triptorelin pamoate How It Works Luteinizing hormone-releasing Healthcare Sales & Marketing Network News: Advanced Stage Advanced Stage Palliative Prostate Cancer Treatment to Be Offered with West an analog of luteinizing hormone releasing hormone (LHRH or GnRH) with Prostate cancer guide - MayoClinic.com Luteinizing hormone-releasing hormone (LH-RH) agonists In men with early-stage prostate cancer, temporary hormone therapy using injections or oral drugs LH and RH agonist info, LH and RH agonist media, health & medical LH-RH agonists/GnRH agonists for prostate cancer Examples Brand Name Chemical Name acetate Trelstar Depot triptorelin pamoate How It Works Luteinizing Healthcare Sales & Marketing Network News: Watson Pharmaceuticals In a study comparing TRELSTARá® DEPOT to the market leading LHRH agonist, TRELSTARá® DEPOT Prostate cancer is the most common cancer in men in the U.S., Paladin and Watson Enter Into Marketing and Supply Agreement for Trelstar(R) 3.75 mg, 1 month slow release, is an injectable, luteinizing hormone-releasing the Canadian market for LHRH agonists for prostate cancer and Hormone Therapy LHRH (luteinizing hormone-releasing hormone) analogs - drugs that decrease Possible side effects of hormone therapy for prostate cancer may include the Hormone Therapy - Prostate Cancer Foundation If prostate cancer is diagnosed at an advanced stage or if the cancer returns after LHRH, or luteinizing-hormone releasing hormone, is one of the key Order Prescription Medication Online. cancer lhrh luteinizing cancer lhrh luteinizing prostate trelstar ö ĺ¸ô’ A non are vasectomy. prostate cancer study on far cancer the cancer Smoking Tĺ’ likely incidence question TRELSTAR - TRELSTAR and Prostate Cancer FAQs TRELSTAR is a prescription drug known as an LHRH (luteinizing hormone-releasing hormone) agonist, used for the management of advanced prostate cancer. TRELSTAR - Welcome to TRELSTAR.com TRELSTARá® Depot and prostate cancer. TRELSTAR LA and TRELSTAR Depot are a type of drug known as a luteinizing hormone releasing hormone (LHRH) agonist University of Chicago Med Ctr: Hormone Therapy For Prostate Cancer Reducing testosterone levels can make the prostate cancer shrink and become LHRH (luteinizing hormone-releasing hormone) analogs - drugs that decrease ACS :: Hormone (Androgen Deprivation) Therapy There are several types of hormone therapy used to treat prostate cancer. Luteinizing hormone-releasing hormone (LHRH) antagonists: A newer drug, Androgen Deprivation Therapy for Prostate Cancer Return to: Chapter 3: Androgen Deprivation Therapy for Prostate Cancer LHRH = luteinizing-hormone releasing hormone; IM = intramuscularly; LH-RH agonists/GnRH agonists for prostate cancer - Revolution Health Luteinizing hormone-releasing hormone (LH-RH) agonists and gonadotropin-releasing LH-RH and GnRH agonists are used to treat advanced prostate cancer. |
| cancer lhrh luteinizing prostate trelstar |
|
cancer hospital prostate rate success adenocarcinoma prostate treatment cancer incidence prostate cancer journal nursing prostate |